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ABSTRACT
Mammalian type I iodothyronine deiodinase (D1) activates and
inactivates thyroid hormone by outer ring deiodination (ORD) and
inner ring deiodination (IRD), respectively, and is potently inhibited
by propylthiouracil (PTU). Here we describe the cloning and charac-
terization of a complementary DNA encoding a PTU-insensitive D1
from teleost fish (Oreochromis niloticus, tilapia). This complementary
DNA codes for a protein of 248 amino acids, including a putative
selenocysteine (Sec) residue, encoded by a TGA triplet, at position
126. The 39 untranslated region contains two putative Sec insertion
sequence (SECIS) elements. Recombinant enzyme expressed in
COS-1 cells catalyzes both ORD of T4 and rT3 and IRD of T3 and T3
sulfate with the same substrate specificity as native tilapia D1 (tD1),
i.e. rT3 .. T4 . T3 sulfate . T3. Native and recombinant tD1 show
equally low sensitivities to inhibition by PTU, iodoacetate, and gold
thioglucose compared with the potent inhibitions observed with mam-
malian D1s. Because the residue 2 positions downstream from Sec is
Pro in tD1 and in all (PTU-insensitive) type II and type III iodothy-
ronine deiodinases but Ser in all PTU-sensitive D1s, we prepared the
Pro128Ser mutant of tD1. The mutant enzyme showed strongly de-
creased ORD and somewhat increased IRD activity, but was still
insensitive to PTU. These results provide new information about the
structure-activity relationship of D1 concerning two characteristic
properties, i.e. catalysis of both ORD and IRD, and inhibition by PTU.
(Endocrinology 138: 5153–5160, 1997)
THE MAJOR secretory product of the thyroid is a pro-hormone, T4, which is activated in peripheral tissues by
outer ring deiodination (ORD) to T3. Both T4 and T3 are
inactivated by inner ring deiodination (IRD) to rT3 and 3,39-
diiodothyronine (3,39-T2), respectively (1–3). Three homolo-
gous iodothyronine deiodinases catalyze these reactions (1–
3). Type I deiodinase (D1) is located in liver, kidney, and
thyroid; has both ORD and IRD activities; prefers rT3 as
substrate; and provides most of plasma T3. Type II deiodi-
nase (D2) and type III deiodinase (D3) show distinct tissue
distributions and contrasting enzyme activities; D2 catalyzes
only ORD and D3 only IRD (1–3). The different deiodinases
that have recently been characterized are '30 kDa proteins,
featuring in corresponding positions a selenocysteine (Sec)
residue that is important for catalysis (4–15). The catalytic
cycle of D1 appears to consist of two half reactions: first,
transfer of an I1 from the substrate to the selenolate (Se2)
anion of Sec, and second, reduction of the selenenyl iodide
(SeI) generated by a thiol cofactor. In vitro, dithiotreitol (DTT)
substitutes for the endogenous cofactor (1–3). 6-n-Propyl-2-
thiouracil (PTU) is a thyroid peroxidase-blocking drug that
is used for treatment of hyperthyroidism. PTU is also a po-
tent inhibitor of mammalian D1 but has no effect on D2 and
D3 (1–3). PTU is an uncompetitive D1 inhibitor that is
thought to react with the SeI intermediate. The nucleophile-
directed reagents iodoacetate (IAc) and gold thioglucose
(GTG) also inhibit D1 more effectively than D2 and D3 (16–
18). Both IAc and GTG are competitive D1 inhibitors that
probably interact with the Se2 anion (1–3).
Before the amino acid sequences of D2 and D3 were
known, the findings that PTU and GTG are less potent in-
hibitors of these enzymes and of the Sec126Cys mutant of D1
than of the wild-type D1 led to the proposal that Sec was
absent in the catalytic centers of D2 and D3 (17, 18). This was
supported by the relatively minor decreases in D2 and D3
activities compared with the strong decreases in hepatic and
renal D1 activities in selenium-deficient rats (19, 20). A D1
variant has recently been identified in the kidney of the
teleost fish Oreochromis niloticus (tilapia), showing charac-
teristic catalytic and substrate specificities but low sensitiv-
ities to inhibition by PTU, IAc, and GTG (21). Similar to D2
and D3, it was proposed that Sec was not present in the active
site of this tilapia D1 (tD1). To determine the molecular basis
for the differences in catalytic mechanisms and inhibitor
sensitivities between the deiodinase isoenzymes, we cloned
and characterized complementary DNA (cDNA) coding for
tD1. This involved RT-PCR of tilapia kidney messenger RNA
(mRNA) using primers based on conserved amino acid se-
quences (NFGSCTSecP and YIEEAH) present in rat, human,
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and dog D1s and Xenopus laevis D3 sequences (4, 5, 7, 8). The
resultant RT-PCR products were sequenced to confirm that
they were related to known deiodinases and used as probes
for cDNA library screening. Expression of the full-length
cDNA clone obtained resulted in production of a functional
deiodinase, the catalytic properties of which were examined.
Materials and Methods
Materials
Tilapia (Oreochromis niloticus) were obtained from CERER-University
of Lie`ge (Tihange, Belgium) and kept as described before (21). TRIzol
reagent was obtained from Gibco BRL (Breda, The Netherlands); oli-
go(dT) cellulose was from New England Biolabs (Beverly, MA); Super-
FIG. 1. Nucleotide and deduced amino acid sequence of cDNA clone TN12. Sec residue is denoted by X. Putative SECIS elements in 39 UTR
are underlined.
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Taq DNA polymerase was from HT Biotechnology (Cambridge, UK);
AMV reverse transcriptase and pCI-Neo were from Promega (Madison,
WI); Klenow DNA polymerase was obtained from Boehringer Mann-
heim GmbH (Mannheim, Germany); pCR-II was from Invitrogen (San
Diego, CA); synthetic oligonucleotides were from Pharmacia Biotech
(Roosendaal, The Netherlands) or Gibco BRL; Hybond membranes and
[a-32P]deoxyATP were purchased from Amersham (Buckinghamshire,
UK); polyethyleneglycol (PEG6000) was from Merck (Hohenbrunn, Ger-
many); diethylaminoethyl (DEAE)-dextran and Sephadex LH-20 were
from Pharmacia. Nonradioactive iodothyronines were obtained from
Henning Berlin R & D (Berlin, Germany), [39,59-125I]T4 ('1200 Ci/mmol)
from Amersham, and [3,5-125I]T3 ('35 Ci/mmol) from Mr. R. Thoma
(Formula GmbH, Berlin, Germany) courtesy of Dr. G. Decker (Hennig
Berlin GmbH, Berlin, Germany). [39,59-125I]rT3 ('2000 Ci/mmol) and
[3,5-125I]T3 sulfate (T3S) were prepared in our laboratory as described
previously (22, 23). PTU, IAc, GTG, DTT, and chloroquine were obtained
from Sigma (St. Louis, MO). All other reagents were of the highest purity
commercially available.
Cloning
Total RNA was isolated from tilapia kidney using TRIzol reagent, and
Poly(A1) RNA was isolated on oligo(dT) cellulose. cDNA was obtained
by oligo(dT)-primed reverse transcription using AMV reverse tran-
scriptase. PCR was performed using the primers 59-AATTTTGGCAGT-
TGTACCTGACC-39 and 59-RTGIGCTTCCTCIATGTA-39 and SuperTaq
DNA polymerase. The PCR products were TA-cloned into pCR-II and
sequenced. The tilapia kidney cDNA library was constructed in Lambda
ZAP-Express (Stratagene, La Jolla, CA). The library was blotted on
Hybond-N1 and screened with the RT-PCR product labeled by primer
extension using Klenow DNA polymerase in the presence of [a-
32P]deoxyATP. The phagemids carried in selected positive bacterio-
phages were excised, generating cDNA clones in pBK-CMV. The inserts
were sequenced manually and by automatic sequencing in both direc-
tions using the dideoxy method of Sanger et al. (23a). Site-directed
mutagenesis was carried out using the MORPH kit (5prime33prime,
Boulder, CO) and the oligonucleotide 59-CACCTGACCCTGGTTTAT-
GTATAA-39; the mutation was confirmed by sequencing. RNA second-
ary structure prediction was done using the MFOLD program provided
by Dr. M. Zuker (Institute for Biomedical Computing, Washington Uni-
versity, St. Louis, MO) on the Internet (http://www.ibc.wustl.edu/
;zuker) (24).
Expression
cDNA was subcloned into pCI-Neo and expressed in COS-1 cells
grown in DMEM/F12 containing 10% FCS (Gibco BRL) and 40 nm
Na2SeO3 (25). One day before transfection, COS-1 cells were seeded at
50% confluency in 55-cm2 cell culture dishes. Expression constructs (7
mg), isolated by alkaline lysis and polyethyleneglycol precipitation (26),
were added to serum-free DMEM/F12 medium containing 100 mg/ml
DEAE-dextran. After 2 h, the medium was replaced by serum-free
DMEM/F12 medium containing 100 mm chloroquine. Again 2 h later the
medium was replaced by DMEM/F12 containing 10% FCS and 40 nm
Na2SO3. After 3 days, the cells were rinsed with PBS; collected in 0.3 ml
0.1 m phosphate (pH 6.9), 1 mm EDTA, and 10 mm DTT; sonicated;
snap-frozen on dry-ice/ethanol; and stored at 280 C.
Northern analysis
Tilapia tissues and microsomal fractions thereof were obtained as
described previously (21). Northern blots were prepared using 20 mg
total tissue RNA and Hybond-N membranes, which were hybridized for
16 h at 60 C with random hexamer-labeled full-length cDNA in 6 3 SSC,
0.5% SDS, 5 3 Denhardts’, and salmon sperm DNA (100 mg/ml). Blots
were washed twice for 15 min at 55 C in 3 3 SSC, 0.5% SDS at 55 C, and
twice for 15 min at 60 C in 1 3 SSC, 0.5% SDS. Autoradiographs were
scanned using a Hewlett Packard Scanjet IIcx (Amstelveen, The Neth-
erlands), and signals were quantified using software developed by Dr.
R. Docter (Department of Internal Medicine III, Erasmus University
Medical School, Rotterdam, The Netherlands). Results were standard-
ized relative to the total amount of RNA applied, which was determined
similarly by photography and quantitation of the fluorescence of the
ethidium bromide-stained gel.
Enzyme assays
Deiodinase activities of native and recombinant enzyme preparations
were analyzed by quantitation of radioiodide released by ORD of outer
ring 125I-labeled T4 or rT3 or by IRD of inner ring
125I-labeled T3 or T3S
(22, 23). In short, appropriate amounts of enzyme protein were incu-
bated in triplicate for 30–60 min at 37 C with 10 nm 125I-labeled substrate
in 0.2 ml 0.1 m phosphate (pH 7.2), 2 mm EDTA, and 10 mm DTT.
Reactions were stopped and [125I]iodothyronines were precipitated by
successive addition of 0.1 ml 5% BSA and 0.5 ml 10% TCA. 125I2 was
further isolated from the supernatant on Sephadex LH-20 minicolumns
(22, 23). Unless indicated otherwise, the results presented are taken from
representative experiments and were reproduced in at least two other
experiments.
Results
By RT-PCR of tilapia kidney mRNA using oligonucleotide
primers corresponding to the conserved amino acid se-
FIG. 2. Predicted secondary structures of two putative SECIS ele-
ments in 39 UTR of tD1 mRNA. Structure on right is exactly as
predicted by the MFOLD program (26), whereas possible basepairing
in loop structure on left has been omitted to enhance homology be-
tween secondary structures. Essential nucleotides identified in con-
sensus SECIS elements (27, 28) are presented in bold.
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quences NFGSCTSecP and YIEEAH, a 117-bp cDNA frag-
ment was obtained, the sequence of which showed high
homology with the corresponding region in mammalian D1s
(4–7). The labeled PCR product was used as a probe to screen
a tilapia kidney cDNA library (200,000 independent clones).
Thirty double-positive clones were identified after plating
500,000 plaque-forming units of the amplified library. Using
vector- and PCR product-specific primers, several possibly
full-length clones were identified by PCR. One clone (TN12)
was found to be 2401 bp long with a reading frame coding
for a 248-amino acid protein, assuming that TGA at codon
position 126 was translated as Sec (Fig. 1). Like the mam-
malian D1s, TN12 contains a large 39 untranslated region
(UTR). RNA secondary structure prediction (24) and com-
parison with published consensus sequences (27, 28) re-
vealed two almost identical, putative Sec insertion sequence
(SECIS) elements (Fig. 2), which are essential for Sec incor-
poration at the UGA opal stop codon.
The deduced amino acid sequence of TN12 showed 48%
identity with rat D1, 48% identity with human D1, and 45%
identity with dog D1 (Fig. 3), including the Sec residue (4, 5,
7). The N-terminal region of TN12 showed a large divergence
from the hitherto described mammalian D1s. We have, there-
fore, sequenced the 59 region of another, independent cDNA
clone that proved to be identical. The TN12 protein appeared
to be much more acidic (pI 7.0) than other D1s (pI 8.7–9.8),
the biological significance of which is unknown. The amino
acid sequence of TN12 showed only 31%, 33%, and 28%
identity with human (13, 14), rat (13, 14), and Fundulus het-
eroclitus (teleost fish) (15) D2, respectively, and 38% identity
with rat (10) and human (11) D3.
A 2.5-kb mRNA was detected on Northern blots by hy-
bridization with labeled TN12 cDNA. The tissue distribution
of this mRNA corresponded very well with that of tD1 ac-
tivity, with highest mRNA and activity levels observed in
kidney (Fig. 4). Shorter exposure of the Northern blot shown
in Fig. 4 revealed only one prominent band of approximately
2.5 kb in kidney.
Enzyme activity expressed in COS-1 cells after transfection
with TN12 cDNA was characteristic for D1 (1–3), showing 1)
catalysis of both ORD and IRD, 2) a clear preference for rT3
as the substrate, and 3) increased IRD of T3S vs. T3 (Fig. 5).
Comparison of TN12-transfected COS-1 cell lysates with
the native enzyme in tilapia kidney microsomes revealed the
same patterns of inhibition of the ORD of [125I]rT3 by (in
decreasing order of potency) rT3, T4, and T3 (Fig. 6). The
apparent Michaelis-Menten constant (Km) value of rT3 for
both native and recombinant enzyme amounted to 2 mm,
which is 5- to 10-fold higher compared with rat and human
D1 (22, 23). Native tD1 and the TN12-encoded enzyme
showed identical patterns of inhibition by (in decreasing
order of potency) GTG, IAc, and PTU (Fig. 7). These results
indicated that both native and recombinant enzyme activities
are approximately 103-fold less sensitive to PTU inhibition,
and approximately 10-fold less sensitive to GTG and IAc
inhibition than rat and human D1 (5, 21).
From the above findings we concluded that TN12 cDNA
encodes the D1 expressed in tilapia kidney. Therefore, the
relative insensitivity of tD1 to PTU, IAc, and GTG does not
appear to be caused by the absence of Sec in its active center.
The amino acid sequence around this Sec residue is highly
conserved among the D1s cloned to date, including chicken
D1 (29). However, the amino acid residue two positions
downstream from Sec is Pro in tD1 but Ser in all other,
PTU-sensitive D1s. Therefore, we produced the Pro128Ser
mutant of tD1 by site-directed mutagenesis, and expressed
the mutant protein in COS-1 cells. It was found that the
mutant catalyzed the ORD of rT3 and T4 at only 2–3% of the
activity of the wild-type enzyme, whereas IRD of T3S was
increased by the mutation (Fig. 8). IRD of T3 by both wild-
FIG. 3. Alignment of amino acid sequences of tilapia, rat, human, and dog type I iodothyronine deiodinases.
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type tD1 and the mutant was too slow to allow accurate
measurements. Addition of 1 mm PTU had little effect on the
ORD of rT3 as well as on the IRD of T3S by the Pro128Ser
mutant (Fig. 9). T4 ORD by the mutant was too slow to exactly
determine the effect of PTU. These results suggest that the
PTU insensitivity of tD1 is not due to the presence of Pro
instead of Ser at position 128.
Discussion
The evidence that the TN12 clone characterized in this
study represents the cDNA coding for tD1 can be summa-
rized as follows: 1) the amino acid sequence of TN12 is much
more homologous with reported D1 sequences from other
species (45–48% identity) than with the D2 sequences (27–
31% identity) or D3 sequences (33–38% identity) from other
species; 2) the tissue distribution of mRNA hybridizing with
FIG. 4. A, Tissue distribution of D1 activity and D1 mRNA levels in
tilapia tissues. Error bars represent SDs of triplicate determinations
(activity) or of two separate experiments (mRNA). B, Northern blot
hybridized with radiolabeled TN12 cDNA.
FIG. 5. ORD of T4 and rT3 and IRD of T3 and T3S by native tD1 in
tilapia kidney microsomes or by recombinant tD1 expressed in COS-1
cells. Conditions were: 10 nM substrate, 10 mM DTT, 1 (lysate) or 0.1
(microsomes) mg protein/ml, and 60 min of incubation at 37 C.
FIG. 6. Inhibition of ORD of [125I]rT3 by native tD1 in tilapia kidney
microsomes (A) or recombinant tD1 expressed in COS-1 cells (B) by
increasing concentrations of unlabeled rT3, T4, and T3. Conditions
were: 10 nM [125I]rT3, 10 mM DTT, 1 (lysate) or 0.1 (microsomes) mg
protein/ml, and 60 (lysate) or 30 (microsomes) min of incubation at 37
C.
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a TN12 cDNA probe and that of tD1 activity are identical,
with kidney as the major site of enzyme production; 3) the
enzyme activity expressed in COS-1 cells transfected with
TN12 cDNA shows identical catalytic potential and substrate
specificity as native tD1 present in tilapia kidney micro-
somes; and 4) recombinant and native enzymes show iden-
tical susceptibilities to inhibition by PTU, IAc, and GTG.
Although we have not directly shown that the enzyme
expressed after transfection of COS-1 cells with tD1 cDNA is
a selenoprotein, indirect evidence strongly suggests that this
is the case. First, mRNA transcribed from tD1 cDNA contains
the opal UGA stop codon at a position identical to that in
other D1 mRNAs shown to be translated as Sec. Furthermore,
like the cDNAs for the other D1s cloned to date, tD1 cDNA
contains a large 39 UTR. Comparison with reported consen-
sus sequences for SECIS elements, which are essential for Sec
incorporation at the UGA codon (27, 28), and RNA secondary
structure prediction (24) reveal that two almost identical,
putative SECIS elements are present in the 39 UTR of tD1.
Although multiple SECIS elements have been described in
selenoprotein P mRNA (27, 30), tD1 is the first deiodinase
mRNA having more than one putative SECIS element. The
function of multiple SECIS elements is unknown, but it may
increase the efficiency of UGA codon read-through. Muta-
tional analyses of mammalian D1s have indicated that the Sec
residue is essential for enzyme activity. Replacement of Sec
by Cys reduces catalytic activity approximately 100-fold,
whereas replacement with Leu results in a complete loss of
enzyme activity (4). Also, the protein truncated at the site of
the Sec residue, which takes place in the absence of a SECIS
element and, hence, if the UGA codon functions as a trans-
lation termination codon, is enzymatically inactive (4).
Therefore, it is impossible that expression of TN12 cDNA
yields a functional deiodinase if the UGA codon were not
translated as Sec.
The most remarkable property of both native and recom-
binant tD1 is their insensitivity to PTU inhibition. Only weak
inhibition is observed with as high as 1 mm PTU, whereas 1
mm of this drug strongly inhibits rat and human D1 (5, 21).
In addition, tD1 is also approximately 10-fold less sensitive
FIG. 7. Inhibition of ORD of [125I]rT3 by native tD1 in tilapia kidney
microsomes (A) or recombinant tD1 expressed in COS-1 cells (B) by
increasing concentrations of GTG, IAc, and PTU. Conditions were: 0.1
mM [125I]rT3, 10 mM DTT, 1 (lysate) or 0.1 (microsomes) mg protein/ml,
and 60 (lysate) or 30 (microsomes) min of incubation at 37 C.
FIG. 8. ORD of T4 and rT3 and IRD of T3 and T3S by wild-type tD1
(WT) and Pro128Ser mutant (PS). Conditions were: 10 nM substrate,
10 mM DTT, 1 mg lysate protein/ml, and 60 min of incubation at 37
C. Percentage deiodination of T4 by WT and PS amounted to 2.3 and
0.1, of rT3 to 14.4 and 0.7, and of T3S to 1.2 and 2.4, respectively.
FIG. 9. Effects of PTU on ORD of rT3 and IRD of T3S by Pro128Ser
mutant of tD1. Conditions were: 0.1 mM substrate, 10 mM DTT, 1 mM
PTU, 1 mg lysate protein/ml, and 120 min of incubation at 37 C.
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to inhibition by GTG and IAc than rat and human D1 (5, 21).
We have demonstrated that this low sensitivity of tD1 to
PTU, IAc and GTG is not caused by the absence of Sec, as
previously hypothesized (21). Therefore, other structural de-
terminants should be responsible for this anomality, one of
which could be the Pro residue two positions downstream
from Sec. All PTU-sensitive deiodinases, i.e. human, rat,
mouse, and dog D1 (4–7), have Ser, and all PTU-insensitive
iodothyronine deiodinases, i.e. all D2s (12–15), all D3s (8–11),
and tD1, have Pro at this position. If PTU inhibition is de-
pendent on the nature of this residue, this could be explained
by differences in effects of Pro and Ser on protein structure
and, thus, on enzyme-inhibitor interaction, or by the require-
ment of the OH group of Ser for reaction of the inhibitors
with Sec. Therefore, we studied the effect of the substitution
of Pro128 by Ser on the catalytic properties of tD1, expecting
that this mutation would increase the PTU sensitivity of the
enzyme. One mm PTU was found to have as little effect on
the Pro128Ser mutant as on the wild-type enzyme, suggest-
ing that the PTU insensitivity of the latter is not solely due
to the presence of Pro instead of Ser at position 128. However,
in particular the low rT3 ORD activity of the Pro128Ser mu-
tant hampers the interpretation of the lack of its inhibition by
PTU (see below). It would be interesting to determine the
effect of the reverse Ser128Pro mutation of other D1s on their
inhibition by PTU.
The lower sensitivities of D2, D3, and tD1 to PTU, IAc, and
GTG compared with mammalian D1s may be caused by the
lower reactivity of the Sec residue. It is unknown whether
other amino acid residues enhance Sec reactivity, much like
Cys and Ser are activated by His and Asp residues in cysteine
and serine proteases (31, 32). Essential His residues have
indeed been identified in D1 (33), and these residues (His158
and His174) are also conserved in tD1. Because PTU suppos-
edly reacts with an enzyme SeI group, the rate of formation
of this intermediate also determines susceptibility to PTU
inhibition. Our findings suggest that tD1 has a lower kcat than
mammalian D1s, because the deiodinase activity expressed
by transfection of COS-1 cells with tD1 is consistently ap-
proximately 10-fold lower than that produced by transfec-
tion with rat D1. This could be explained by a lower reactivity
of Sec in tD1 than in mammalian D1, although the amount
of tD1 protein expressed is unknown. In this regard it should
be mentioned that the basic Arg and Lys residues at positions
11 and 12 of mammalian D1, which are important for mem-
brane insertion (34), are lacking in tD1. Interestingly, a Phe
residue that has been shown to be involved in rT3 binding to
mammalian D1 (7, 22) is also conserved in tD1 (Phe65).
The Pro128Ser mutation in tD1 results in a selective and
strong reduction of its ORD activity, whereas its IRD activity
is not affected or even increased. These findings suggest that
protein structural changes induced by the Pro128Ser muta-
tion interfere in the interaction with substrates undergoing
ORD, whereas they do not affect the interaction with sub-
strates undergoing IRD. This is remarkable, because all other
D1s that have Ser at this position catalyze ORD very effec-
tively. Therefore, the catalytic specificities of the different
deiodinases must be determined by additional structural
elements in these proteins. Further mutational analyses
should reveal the molecular basis for D1 having both ORD
and IRD activity as opposed to D2 and D3, which have only
ORD or only IRD activity, respectively, as well as for the
different inhibitor susceptibilities of the different deiodinase
isoenzymes. This may lead to the rational design of new and
potent deiodinase inhibitors for research and clinical
application.
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